Matt Abernethy's Net Worth

Matt Abernethy's net worth is estimated to be at least $6,977,438.77 as of 03/04/2024. CoreStreet's estimation of Matt Abernethy's net worth is based on their sale of stock and current holding of stock.

Matt Abernethy is CFO at Neurocrine Biosciences Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,352 units of NBIX stock on 02/13/2024. Their biggest sale was on 02/07/2023 when they sold 26,328 units of Neurocrine Biosciences Inc stock for $2,695,987.20. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $6,977,438.77
Most recent insider trade:
  • Feb. 13, 2024

Matt Abernethy's Insider Trading History

Neurocrine Biosciences IncTitleAmountPriceTypeTotal Value
Feb. 13, 2024
CFO1,352$132.85Sell$179,613.20
Feb. 8, 2024
CFO980$134.21Sell$131,525.80
Feb. 6, 2024
CFO1,280$142.19Sell$182,003.20
Jan. 31, 2024
CFO1,283$140.72Sell$180,543.76
Aug. 21, 2023
CFO2,132$107.39Sell$228,955.48
Feb. 7, 2023
CFO26,328$102.40Sell$2,695,987.20
Jan. 31, 2023
CFO1,283$109.98Sell$141,104.34
Feb. 7, 2022
CFO3,310$80.79Sell$267,414.90
Dec. 1, 2021
CFO1,645$82.59Sell$135,860.55
Feb. 8, 2021
CFO2,910$116.82Sell$339,946.20
Dec. 1, 2020
CFO1,645$94.66Sell$155,715.70
May 7, 2020
CFO15,000$110.21Sell$1,653,150.00
April 28, 2020
CFO1,741$102.49Sell$178,435.09
Feb. 7, 2020
CFO2,030$103.35Sell$209,800.50
Dec. 2, 2019
CFO1,645$116.33Sell$191,362.85
Dec. 3, 2018
CFO1,178$90.00Sell$106,020.00